Toggle Nav

XMD17-109

In stock
Catalog No.
A3942
ERK-5 inhibitor
Grouped product items
SizePriceStock Qty
10mM (in 1mL DMSO)
$197.00
In stock
5mg
$105.00
In stock
25mg
$335.00
In stock
100mg
$699.00
In stock

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

XMD17-109 is a new inhibitor of ERK5, IC50 value in HeLa cell is 0.09 ± 0.03 μM, and in vitro, Enzymatic IC50 value is 0.162 ± 0.006 μM.

XMD17-109 is capable of inhibiting the ERK5 autophosphorylation in cells.[1]

Through intravenous injection and oral delivery of XMD17-109 in mice, the pharmacokinetic properties of this compound are as bellows: the T1/2 (half time) is 8.2 h, the plasma clearance is 8.64 mL/min/Kg (data of intravenous injection), the AUC (area under the curve) of oral delivery is 15745 h*ng/mL and the oral bioavailability is 90%.

Reference:
1.  Deng, X., et al., Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones. European Journal of Medicinal Chemistry, 2013. 70: p. 758-767.

Chemical Properties

Physical AppearanceA solid
StorageStore at -20°C
M.Wt638.8
Cas No.1435488-37-1
FormulaC36H46N8O3
SynonymsXMD17 109
Solubility≥31.95 mg/mL in DMSO, ≥86.6 mg/mL in EtOH, <2.48 mg/mL in H2O
SDFDownload SDF
Canonical SMILESCN1CCN(C2CCN(C(C3=CC(OCC)=C(NC4=NC=C5C(N(C6CCCC6)C(C=CC=C7)=C7C(N5C)=O)=N4)C=C3)=O)CC2)CC1
Shipping ConditionEvaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.

Biological Activity

Description XMD17-109 is a novel, specific inhibitor of ERK-5 with an EC50 value of 4.2 μM in HEK293 cells.
Targets ERK-5          
IC50 4.2±0.69 μM(EC50, in HEK 293 cells)          

Quality Control